WO2022114803A1 - Ensemble d'amorces pour identification personnelle et diagnostic d'infection virale respiratoire, et son utilisation - Google Patents
Ensemble d'amorces pour identification personnelle et diagnostic d'infection virale respiratoire, et son utilisation Download PDFInfo
- Publication number
- WO2022114803A1 WO2022114803A1 PCT/KR2021/017470 KR2021017470W WO2022114803A1 WO 2022114803 A1 WO2022114803 A1 WO 2022114803A1 KR 2021017470 W KR2021017470 W KR 2021017470W WO 2022114803 A1 WO2022114803 A1 WO 2022114803A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- seq
- nucleotide sequence
- pair consisting
- primer pair
- primer
- Prior art date
Links
- 238000003745 diagnosis Methods 0.000 title claims abstract description 21
- 206010062106 Respiratory tract infection viral Diseases 0.000 title abstract description 7
- 241000700605 Viruses Species 0.000 claims abstract description 50
- 239000002773 nucleotide Substances 0.000 claims description 91
- 125000003729 nucleotide group Chemical group 0.000 claims description 91
- 230000000241 respiratory effect Effects 0.000 claims description 38
- 238000000034 method Methods 0.000 claims description 19
- 230000009385 viral infection Effects 0.000 claims description 18
- 241000711573 Coronaviridae Species 0.000 claims description 15
- 241000709661 Enterovirus Species 0.000 claims description 15
- 241000712431 Influenza A virus Species 0.000 claims description 15
- 241000713196 Influenza B virus Species 0.000 claims description 15
- 241000351643 Metapneumovirus Species 0.000 claims description 14
- 241000701161 unidentified adenovirus Species 0.000 claims description 14
- 239000000203 mixture Substances 0.000 claims description 12
- 238000001514 detection method Methods 0.000 claims description 11
- 238000005251 capillar electrophoresis Methods 0.000 claims description 10
- 238000002156 mixing Methods 0.000 claims description 9
- 230000003321 amplification Effects 0.000 claims description 8
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 8
- 230000002068 genetic effect Effects 0.000 claims description 7
- 241001678559 COVID-19 virus Species 0.000 claims 1
- 238000004458 analytical method Methods 0.000 abstract description 9
- 108700005077 Viral Genes Proteins 0.000 abstract description 3
- 238000012408 PCR amplification Methods 0.000 abstract description 2
- 108091092878 Microsatellite Proteins 0.000 abstract 2
- 239000000047 product Substances 0.000 description 19
- 108090000623 proteins and genes Proteins 0.000 description 12
- 108020004414 DNA Proteins 0.000 description 9
- 208000023504 respiratory system disease Diseases 0.000 description 8
- 238000010586 diagram Methods 0.000 description 7
- 238000000246 agarose gel electrophoresis Methods 0.000 description 4
- 239000002299 complementary DNA Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- 238000002198 surface plasmon resonance spectroscopy Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 3
- -1 DNA or RNA Chemical class 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 238000012790 confirmation Methods 0.000 description 3
- 238000002405 diagnostic procedure Methods 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 210000002919 epithelial cell Anatomy 0.000 description 3
- 239000003446 ligand Substances 0.000 description 3
- 102000007325 Amelogenin Human genes 0.000 description 2
- 108010007570 Amelogenin Proteins 0.000 description 2
- 208000035473 Communicable disease Diseases 0.000 description 2
- 229920000742 Cotton Polymers 0.000 description 2
- 230000004544 DNA amplification Effects 0.000 description 2
- 102100034343 Integrase Human genes 0.000 description 2
- 206010035664 Pneumonia Diseases 0.000 description 2
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 2
- 241000725643 Respiratory syncytial virus Species 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000000084 colloidal system Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 241001493065 dsRNA viruses Species 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000013537 high throughput screening Methods 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 230000002285 radioactive effect Effects 0.000 description 2
- 238000003753 real-time PCR Methods 0.000 description 2
- 238000003757 reverse transcription PCR Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000001847 surface plasmon resonance imaging Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 229920003002 synthetic resin Polymers 0.000 description 2
- 239000000057 synthetic resin Substances 0.000 description 2
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 description 2
- 241000712461 unidentified influenza virus Species 0.000 description 2
- GZCWLCBFPRFLKL-UHFFFAOYSA-N 1-prop-2-ynoxypropan-2-ol Chemical compound CC(O)COCC#C GZCWLCBFPRFLKL-UHFFFAOYSA-N 0.000 description 1
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 1
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- BZTDTCNHAFUJOG-UHFFFAOYSA-N 6-carboxyfluorescein Chemical compound C12=CC=C(O)C=C2OC2=CC(O)=CC=C2C11OC(=O)C2=CC=C(C(=O)O)C=C21 BZTDTCNHAFUJOG-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 102000013563 Acid Phosphatase Human genes 0.000 description 1
- 108010051457 Acid Phosphatase Proteins 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 108090001008 Avidin Proteins 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- 108020004635 Complementary DNA Proteins 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 101150013191 E gene Proteins 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 108010067770 Endopeptidase K Proteins 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 238000010222 PCR analysis Methods 0.000 description 1
- 239000002033 PVDF binder Substances 0.000 description 1
- 208000002606 Paramyxoviridae Infections Diseases 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 108010004729 Phycoerythrin Proteins 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 101710118046 RNA-directed RNA polymerase Proteins 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 241000315672 SARS coronavirus Species 0.000 description 1
- 108010090804 Streptavidin Proteins 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Natural products NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 238000005571 anion exchange chromatography Methods 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 229940125716 antipyretic agent Drugs 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000000120 cytopathologic effect Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 1
- 238000002795 fluorescence method Methods 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000003365 glass fiber Substances 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 238000007403 mPCR Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 239000011325 microbead Substances 0.000 description 1
- 239000004005 microsphere Substances 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 108091027963 non-coding RNA Proteins 0.000 description 1
- 102000042567 non-coding RNA Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 238000003752 polymerase chain reaction Methods 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 1
- 239000003161 ribonuclease inhibitor Substances 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000001542 size-exclusion chromatography Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 230000005727 virus proliferation Effects 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
Abstract
La présente invention concerne un jeu d'amorces pour l'identification des personnes et le diagnostic des infections virales respiratoires, et une utilisation de ce dernier. Plus particulièrement, un ensemble d'amorces selon la présente invention permet de détecter simultanément un locus, pouvant identifier un individu, et un gène viral cible en utilisant l'analyse des répétitions en tandem courtes (STR) et l'amplification par PCR, et peut donc être utilisé efficacement pour déterminer, en une seule fois, quel individu est infecté par quel virus.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR10-2020-0160100 | 2020-11-25 | ||
| KR20200160100 | 2020-11-25 | ||
| KR1020210163151A KR20220073673A (ko) | 2020-11-25 | 2021-11-24 | 개인식별 및 호흡기 바이러스 감염 진단용 프라이머 세트 및 이의 용도 |
| KR10-2021-0163151 | 2021-11-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2022114803A1 true WO2022114803A1 (fr) | 2022-06-02 |
Family
ID=81754632
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/KR2021/017470 WO2022114803A1 (fr) | 2020-11-25 | 2021-11-25 | Ensemble d'amorces pour identification personnelle et diagnostic d'infection virale respiratoire, et son utilisation |
Country Status (1)
| Country | Link |
|---|---|
| WO (1) | WO2022114803A1 (fr) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090148830A1 (en) * | 1998-09-24 | 2009-06-11 | Innogenetics N.V. | Identification of microorganisms causing acute respiratory tract infections (ari) |
| KR101533792B1 (ko) * | 2015-02-24 | 2015-07-06 | 대한민국 | Ngs 기반 인간 객체의 상염색체 분석방법 |
| CN106048096A (zh) * | 2016-08-16 | 2016-10-26 | 无锡市疾病预防控制中心 | 一种同时检测四种呼吸道病毒的rt‑pcr方法所用的四对上下游引物 |
| US20170349946A1 (en) * | 2014-10-24 | 2017-12-07 | University Of Portsmouth Higher Education Corporation | Cell assay kit and method |
-
2021
- 2021-11-25 WO PCT/KR2021/017470 patent/WO2022114803A1/fr active Application Filing
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090148830A1 (en) * | 1998-09-24 | 2009-06-11 | Innogenetics N.V. | Identification of microorganisms causing acute respiratory tract infections (ari) |
| US20170349946A1 (en) * | 2014-10-24 | 2017-12-07 | University Of Portsmouth Higher Education Corporation | Cell assay kit and method |
| KR101533792B1 (ko) * | 2015-02-24 | 2015-07-06 | 대한민국 | Ngs 기반 인간 객체의 상염색체 분석방법 |
| CN106048096A (zh) * | 2016-08-16 | 2016-10-26 | 无锡市疾病预防控制中心 | 一种同时检测四种呼吸道病毒的rt‑pcr方法所用的四对上下游引物 |
Non-Patent Citations (1)
| Title |
|---|
| L. J. R. VAN ELDEN , M. NIJHUIS , P. SCHIPPER , R. SCHUURMAN , A. M. VAN LOON: "Simultaneous detection of influenza viruses A and B using real-time quantitative PCR", JOURNAL OF CLINICAL MICROBIOLOGY, vol. 39, no. 1, 1 January 2001 (2001-01-01), US , pages 196 - 200, XP002604453, ISSN: 0095-1137, DOI: 10.1128/JCM.39.1.196-200.2001 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR20100044736A (ko) | 눈과 중앙 신경조직의 세균성, 균성, 기생성 및 바이러스성 감염을 동시에 검출 및 판별하기 위한 신규한 방법 | |
| WO2013042824A1 (fr) | Puce à adn destinée au diagnostic de maladies infectieuses de l'appareil génito-urinaire | |
| WO2017074094A1 (fr) | Procédé de diagnostic prénatal à l'aide de la pcr numérique. | |
| WO2011025262A2 (fr) | Composition pour détecter séparément le complexe mycobacterium tuberculosis et le genre mycobacterium, et procédé pour détecter simultanément mycobacterium tuberculosis et le genre mycobacterium par réaction de polymérase en chaîne multiplexée en temps réel utilisant celle-ci | |
| WO2017122897A1 (fr) | Marqueur génétique servant à détecter le virus responsable de l'iridovirose de la daurade japonaise, et procédé de détection du virus causal utilisant le marqueur | |
| WO2014010806A1 (fr) | Informations fournissant une méthode pour le diagnostic de la tuberculose à l'aide d'une réaction en chaîne de la polymérase-transcriptase inverse en temps réel ciblée par un arnm ip-10 | |
| WO2021162228A1 (fr) | Ensemble d'amorces pour l'analyse de la résistance aux médicaments du vih-1, kit le comprenant et procédé d'analyse l'utilisant | |
| WO2021177773A2 (fr) | Composition pour le diagnostic du sars-cov-2, kit, et procédé pour le diagnostic du sars-cov-2 l'utilisant | |
| WO2022114803A1 (fr) | Ensemble d'amorces pour identification personnelle et diagnostic d'infection virale respiratoire, et son utilisation | |
| WO2016056796A1 (fr) | Trousse de détection des virus de la grippe aviaire à sensibilité élevée, composition de sonde et puce génétique destinées à cette trousse pour la détection des virus de la grippe aviaire, et procédé de détection des virus de la grippe aviaire à l'aide de cette trousse | |
| WO2012002597A1 (fr) | Amorce destinée à diagnostiquer le virus de l'hépatite b, sonde, kit comprenant celles-ci, et procédé de diagnostic du virus de l'hépatite b utilisant le kit | |
| WO2022145658A1 (fr) | Composition pour diagnostiquer une maladie de tsutsugamushi et kit la comprenant | |
| WO2011142646A9 (fr) | Procédé de détection de hpv (papillomavirus humain) et de son génotype | |
| WO2020101194A1 (fr) | Ensemble d'amorces pour une réaction d'amplification isothermique médiée par boucle pour diagnostiquer des entérobactéries productrices de carbapénèmase, et utilisation correspondante | |
| WO2019221537A1 (fr) | Procédé de détection de mycoplasme à l'aide d'adn mitochondrial en tant qu'échantillon témoin interne | |
| WO2022119204A1 (fr) | Analyse ciblée du génome pour prédire l'efficacité d'un agent immunothérapeutique contre le cancer, y compris l'identification de l'ebv | |
| WO2018048194A1 (fr) | Composition et procédé pour améliorer la sensibilité et la spécificité de la détection d'acides nucléiques à l'aide d'une protéine dcas9 et de la liaison d'arng à une séquence d'acide nucléique cible | |
| WO2020153673A1 (fr) | Ensembles d'amorces universelles pour la détection de flavivirus et leur utilisation | |
| EP3368690A1 (fr) | Procédé de diagnostic prénatal à l'aide de la pcr numérique. | |
| WO2021107713A1 (fr) | Procédé de diagnostic de la sclérose latérale amyotrophique sur la base d'un marqueur de mutation du gène lats1 | |
| WO2021141179A1 (fr) | Oligonucléotide et plasmide pour la détection simultanée de quatre sérotypes du virus de la dengue, et procédé d'analyse du sérotype du virus de la dengue utilisant celui-ci | |
| WO2020171596A1 (fr) | Composition pour la détection d'un micro-organisme du genre ganoderma et pour le diagnostic de la pourriture racinaire, et procédé d'utilisation correspondant | |
| WO2021154042A2 (fr) | Ensemble d'amorces pour une réaction d'amplification multi-isotherme à haute sensibilité capable de cribler et de détecter simultanément la mycobacterium tuberculosis et des mycobactéries non tuberculeuses | |
| WO2010128724A1 (fr) | Amorce, sonde et procédé de détection du papillovirus humain | |
| WO2021215556A1 (fr) | Procede de preparation d'un kit de diagnostic de coronavirus, kit de diagnostic de coronavirus ainsi preparé, et procédé de diagnostic de coronavirus l'utilisant |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 21898629 Country of ref document: EP Kind code of ref document: A1 |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 21898629 Country of ref document: EP Kind code of ref document: A1 |